(Q34561153)

English

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

0 references

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

allergic rhinitis

1 reference

based on heuristic

inferred from title

Giovanni Passalacqua

6

object named as

Giovanni Passalacqua

1 reference

Europe PubMed Central

3 August 2017

Giorgio Walter Canonica

7

object named as

Giorgio Walter Canonica

1 reference

Europe PubMed Central

3 August 2017

author name string

Martin Penagos

1

1 reference

Europe PubMed Central

3 August 2017

Enrico Compalati

2

1 reference

Europe PubMed Central

3 August 2017

Francesco Tarantini

3

1 reference

Europe PubMed Central

3 August 2017

Rodrigo Baena-Cagnani

4

1 reference

Europe PubMed Central

3 August 2017

Jose Huerta

5

1 reference

Europe PubMed Central

3 August 2017

publication date

1 August 2006

1 reference

Europe PubMed Central

3 August 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

3 August 2017

97

1 reference

Europe PubMed Central

3 August 2017

141-148

1 reference

Europe PubMed Central

3 August 2017

2

1 reference

Europe PubMed Central

3 August 2017

Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The WHO ARIA (allergic rhinitis and its impact on asthma) initiative

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in upper airway diseases and allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Noninjection routes for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy in pediatric patients: beyond clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety of sublingual-swallow immunotherapy: an analysis of published studies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Position paper: Immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice. Allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulation during sublingual therapy in allergic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B immunization coverage among Vietnamese-American children 3 to 18 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analyses and large randomized, controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960004-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)60004-X

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34561153&oldid=1639158118"